OBJECTIVE: To investigate linkage and association between the leptin receptor (LEPR) gene and body composition variables in the Que Â bec Family Study (QFS). DESIGN: Single-point linkage analysis using families, and covariance and chi-square analyses using normal weight and obese unrelated subjects from QFS. SUBJECTS: 169 nuclear families were used for linkage study. 308 unrelated subjects (146 males; 162 females) from these families were used for chi-square testing of genotype and allele distributions between subjects with body mass index (BMI)`27 kgam 2 (n 167) and those with BMI ! 27 kgam 2 (n 141), and for a series of covariance analyses using age, plus height for fat mass (FM) and fat free mass (FFM), as covariates. A corrected P value (P*) for multiple tests has been calculated according to P* 1-(1-P) number of phenotypes . MEASUREMENTS: Variables were BMI (in kgam 2 ), sum of six skinfolds (SF6 in mm), FM (in kg), percent body fat (%FAT) and FFM (in kg). Polymerase chain react restricted fragment length polymorphisms PCR-RFLP) was used to identi®ed a K109R substitution in exon 4, a Q223R in exon 6, a K656N in exon 14 and an automatic DNA sequencer for a CA microsatellite repeat in intron 3, and heteroduplex pattern on non-denaturing gel for a CTTT repeat in intron 16. RESULTS: Good evidence of linkage was observed for Q223R with FM (P 0.005; P* 0.02), and for the CTTT repeat with FFM (P 0.007; P* 0.03). Weaker linkages (0.02 P 0.05) were also observed between Q223R and BMI, SF6 and FFM, between the CA repeat and BMI, SF6 and FM, and between the CTTT repeat and FM. Moreover, FFM values were found to be different among genotypes for the CTTT repeat polymorphism with heavier females, carriers of the 123* allele at the CTTT repeat, showing 4 kg less of FFM (43.6 AE 1.0, n 21 vs 47.7 AE 0.8, n 30; P 0.005; P* 0.02) than non-carriers. Also, at the Q223R polymorphism, in lower BMI males, carriers of the Q223 allele were 4 kg lighter in FFM (53.4 AE 0.6, n 47 vs 56.6 AE 0.9, n 18; P 0.005; P* 0.02) than non-carriers. No signi®cant differences were observed between lower and higher BMI subjects in genotype and allele frequency distributions for any of the polymorphisms. CONCLUSIONS: These results indicate that the LEPR gene is involved in the regulation of the body composition in human particularly of FFM in the QFS.
Introduction
Obesity has been shown to have a complex etiology, resulting from the combined effects of genes, environment, lifestyle and their interactions. 1 Five singlegene mutation models in mouse (ob, db, fat, tub, agouti) are known to result in obesity and, for some strains, in diabetes. 2, 3 All the genes responsible for these mutations have now been cloned in both rodents and human (see Ref 4 for a review).
The rodent leptin and leptin receptor gene products have de®ned a new biological pathway for the regulation of food intake and energy expenditure. Leptin is released from adipocytes as a signal of body fat stores and acts as a satiety factor with its receptor located in the hypothalamus, a brain area known to be involved in the regulation of food intake. 3,5 ± 710 The leptin receptor Lepr gene is mutant in the db mouse, and in the Zucker (fa) and Kaletsky (fa k ) rats, 11 ± 19 producing an early-onset severe obesity. Five differentially spliced transcripts, four long isoforms that include the transmembrane domain and differing proportions of the intracellular domain of the protein, and one short and soluble form without these domains, have been observed. 20 In the db mouse, a point mutation creates a splice-donor site in the 3 H -UTS of the penultimate exon 17, resulting in a frame shift which creates a truncated, non functional variant of the long (Rb) isoform of the molecule. 20, 21 In the fa rat, the mutation in Lepr results in a single amino acid substitution Q269P reducing intracellular transport capacity of Lepr, 13 possibly by interfering in its dimerization and perhaps by activating constitutively the Lepr receptor. 18 Finally, in the fa k rats, a non-sense mutation at codon 763, coding for a tyrosine residue, introduces a stop codon in the extracellular domain of Lepr, resulting in a truncated non-functional receptor. 16, 17 Both rat fa and fa k mutations result in a de®cient plasma to cerebrospinal-¯uid (CSF) transport of leptin. 16 The human leptin receptor LEPR gene 22 maps to 1p31-p22. 23 No linkage was observed between markers in the vicinity of LEPR and obesity in Pima Indians, 24 ± 26 as in a French population, 27 whereas suggestive linkages were reported in the Que Âbec Family Study (QFS). 28 Some 18 different polymorphisms in the human LEPR gene have been reported (Figure 1 ). Nine allelic variations in exon coding sequences of the gene, six of them resulting in amino acid changes, as well as six nucleotide changes and two microsatellite repeats in different introns, an alternative spliced transcript, the skipping of exon 8 and a 45 bp insertionadeletion in the 3
H -UTS region of the gene, have been reported. 29 ± 36 The Q223R polymorphism was not shown to associate with obesity in seven lean and eight obese subjects. 29 On the other hand, allele frequencies were shown to be different between 10 lean and 10 obese Pima Indians for two intronic IVS16-36AaT and IVS19 37CaA, and an exonic 3057GaA (P1019P) nucleotide change (P 0.003), and for haplotypes of the same three allelic variants and the Q223R substitution (P 0.001). 32 In a British male population, the K109R, Q223R, S343S, K656N and P1019P exonic polymorphisms were studied, and no signi®cant differences in allele or genotype frequency distributions were observed between normal weight and obese (body mass index, BMI b 28 kgam 2 ) subjects, whereas a weak association with BMI (P 0.02) was observed with the K656N allelic variant, but only in normal weight subjects. 33 On the other hand, no signi®cant differences between genotypes of the Q223R and K656N variants were observed for BMI or the waist-to-hip ratio (WHR) among lean (mean BMI 21.0AE 1.4 kgam 2 ) and obese (mean BMI 30.5AE 2.9 kgam 2 ) subjects in an American population 37 or with BMI over time (7 ± 47 y) for the same two polymorphisms and the K109R substitution in a group of Danish men with or without a history of juvenile onset obesity. 34 No signi®cant differences in allele frequencies between non-obese (BMI 21.6AE 2.2 kgam 2 ) and obese (BMI 35.1 AE 6.5 kgam 2 ) Japanese subjects were observed for the K109R, Q223R, A976D and P1019P polymorphisms. 35 No differences in allele or genotype distributions of the 45 bp insertionadeletion polymorphism in the 3
H -UTS region of LEPR were observed between normal weight and morbidly obese (BMI ! 40 kgam 2 ) subjects. 27 Recently, a splice-mutation producing a skipping of exon 18, resulting in a truncated leptin receptor lacking both the transmembrane and the intracellular portion of LEPR, has been reported in a consanguinous family of Kabilian origin. 36 In this family of nine children, three sisters were shown to be homozygotes for the mutation, which produced an early-onset morbid obesity developing in the ®rst months of life, with hyperphagia, hypogonadotropic hypogonadism but, in contrast to db mouse, normal Leptin receptor gene and body composition YC Chagnon et al glycaemia and insulinaemia, and normal triglyceridaemia and cholesterolaemia. 36 But there is no strong evidence yet that DNA sequence variations in the LEPR gene contributes to the more common forms of human obesity.
We used restriction fragment length polymorphisms (RFLPs) detecting amino acid substitutions in exon 4, 6, and 14, 31 and microsatellite repeats located in intron 3 and 16 30 of the LEPR gene (underlined in Figure 1 ), to test for linkage and association with adiposity-related and body composition variables in the QFS. Linkages were observed with four of the ®ve phenotypes considered, and positive associations were detected with body composition phenotype.
Material and methods

Subjects and phenotypes
The QFS cohort has been previously described. 38 Caucasian nuclear families from the greater Que Âbec City area were tested for a battery of morphometric and physiologic variables. Blood samples were obtained for various biochemical assays and permanent lymphoblastoid cell lines were established for the extraction of DNA. Only subjects over the age of 18 y were retained for the present study. A total of 679 subjects (42 grandparents, 307 parents and 330 adult offspring) from 169 families were available for the study. Dependent variables include the BMI (weight in kg divided by height in squared meters, kgam 2 ), the percent body fat (%FAT), estimated from body density measurements obtained by underwater weighing 39 and the equation of Siri 40 , and the fat mass (FM in kg) and fat free mass (FFM in kg) calculated from %FAT and body weight. Pulmonary residual volume was assessed by the helium dilution technique. 41 Subcutaneous fat (in mm) was estimated by the sum of six skinfold thicknesses (SF6 abdominal, subscapular, suprailiac, medial calf, triceps and biceps).
Molecular analysis
Genomic DNA was prepared from permanent lymphoblastoid cells by the proteinase K and phenolachloroform technique. DNA was dialysed four times against TE buffer (10 mM Tris, 1 mM EDTA pH 8.0) for 6 h at 4 C and ethanol precipitated. The three RFLPs and the two microsatellite markers used in the study, have been described elsewhere. 30, 31 Polymerase chain reaction (PCR) was performed using 100 ng genomic DNA, 30 pmoles of each primer, 250 uM dNTP's and 1 U Taq polymerase in PCR buffer (Boehringer Mannheim, Mannheim, Germany) with 1.5 mM MgCl 2 for a ®nal volume of 20 ul. PCR cycles consisted of 30 ± 35 cycles at 94 C for 30 s, annealing at 55 C for 30 s and extension at 72 C for 30 s (Perkin Elmer 9600). PCR products were digested for 12 h at 37 C with, respectively, 10 U of Hae III, 20 U of Msp I, or 10 U of Mvn I, restriction enzymes for the K109R, Q223R and K656N polymorphisms. The microsatellite dinucleotide repeat was analysed using automatic DNA sequencers (ABI 373, San Francisco, CA; Licor, Lincoln, Nebraska).
Statistical analysis
Before linkage and association studies, phenotypic variables were adjusted, within gender, for age and age square using a regression procedure. Residuals were then standardized to a mean 0 and a standard deviation of 1. The sib-pair linkage analysis was performed on nuclear families from the different generations using the SIBPAL version 3.0 software from the SAGE package, 42 with the t-statistic and the degree of freedom adjusted for the non-independence of the sib-pairs. Association studies were undertaken on unrelated subjects, selected as follows: all unrelated parents, one parent chosen at random from parental sibships, the adult offspring with BMI ! 27 kgam 2 for families without parent, or one of those adult offspring with a BMI ! 27 kgam 2 chosen at random. The phenotypes were compared between genotypes using covariance analysis with age, age square, gender, plus height for FM and FFM, and BMI status (`27 vs ! 27 kgam 2 ) as covariates, and by BMI status and by gender using age and age square, plus height for FM and FFM, as covariates. Allele frequency and genotype distributions were compared between subjects with BMI`27 kgam 2 and those with BMI ! 27 kgam 2 by chi-square (n 308). The SAS package (version 6.08) for PC was used for the analysis. Bonferroni corrected P values (P*) of the linkage and association tests for multiple tests were calculated using P* 1 7 (1 7 P) number of phenotypes .
Results
Observed allele frequencies for the three RFLPs and for the two microsatellite markers of LEPR in QFS are presented in Table 1 . The heterozygosity level for these polymorphisms reaches 0.41, 0.50 and 0.35, for the RFLPs, and 0.49 and 0.56 for the two repeats. All polymorphisms were in Hardy-Weinberg equilibrium, and in linkage disequilibrium with each other. The exonic polymorphisms allele frequencies are very similar to those reported in the Centre d'Etude du Polymorphisme. Humain (CEPH) families 27 and in British, 33 Danish, 34 American 37 and Japanese 35 populations, except for the Q223R polymorphism in the Japanese 35 and in another non-Caucasian population of Pima Indians, 32 which showed strong differences (Table 1) . Therefore, allelic variations in LEPR show a signi®cant race andaor population component.
Descriptive statistics of the different phenotypic variables in QFS subjects from each of the four generation by gender groups are shown in Table 2 . Table 3 . The number of sib-pairs varied according to the combination of marker and phenotype, ranging from 268 ± 276 pairs for FM, %FAT and FFM, and from 311 ± 325 for BMI and SF6. Good evidence of linkage was observed between Q223R in exon 6 and FM (P 0.005; P* 0.02), and between the CTTT repeat in intron 16 and FFM (P 0.007; P* 0.03). Weaker linkages (0.02 P 0.05) were also observed between Q223R and BMI, SF6 and FFM, between the CA repeat in intron 3 and BMI, SF6, and FM, and the CTTT repeat and FM. The use of exon haplotypes did not improve the linkage results (data not shown). Only one suggestive linkage with FM (P 0.04) was present when exonic haplotypes were tested.
Genotype and allele frequency distributions for the different polymorphisms were compared using a chisquare test between subjects with BMI`27 kgam 2 and those with BMI ! 27 kgam 2 . No signi®cant differences were observed ( Table 4 ). The allele frequencies were also identical when comparisons were made among BMI quintiles, and for the haplotypes of the exon allelic variants (data not shown).
Association studies were also conducted by comparing values of the phenotypic variables across the genotypes of the different polymorphisms with a Finally, weaker evidence of an association was also observed for FFM in leaner males for the Q223R polymorphism (P 0.02; data not shown) with carriers of the Q223 allele having 4 kg less FFM (53.4 AE 0.6, n 47 vs 56.6 AE 0.9, n 18; P 0.005; P* 0.02) than non-carriers.
Discussion
No signi®cant differences in allele frequencies or genotype distributions were observed between leaner and heavier subjects in QFS as in other studies of British, 33 Danish, 34 French, 27 American, 37 or Japanese 35 populations. To a certain extent, these results are not surprising considering the polygenic nature of most human obesity cases, in which each individual gene is expected to contribute in a minor way to the phenotypic variation. In addition, different combinations of allelic variants from different genes may predispose or not to obesity. This phenomenon can obscure differences in genotype or allele frequencies between normal weight and obese subjects, particularly when comparison is undertaken one gene at a time. Finally, it is obvious from our results in QFS and from those of other studies, that the same allelic variant does not necessarily have the same effect in different genetic environments such as in normal weight vs obese or male vs female subjects.
We have observed here linkages between three out of the ®ve polymorphisms of LEPR and body composition phenotypes, with FM and FFM showing the strongest results with the Q223R and CTTT repeat polymorphisms, respectively. Only a weak association between FFM and Q223R was observed in contrast to the linkages observed with FM, BMI and SF6 (Table  3) . On the other hand, no linkages were observed with K656N, but signi®cant associations with FFM were detected. This apparent discrepancy between positive linkage but negative association, and vice-versa, can be explained by the nature of linkage analysis, which does not take into account which allele is shared by sibs, vs that of association study, which is based on such allele differences, and by the higher sensitivity of association studies. 43, 44 As a result, positive linkage can be observed in a population sample for sets of alleles, and this will not be necessarily re¯ected in association studies where the effect of a speci®c allele is tested. The K656N polymorphism has a lower heterozygosity in QFS than the Q223R and CTTT microsatellite repeat (0.35 vs 0.49 and 0.56), which could also explain, in part, negative linkage results with FFM (P 0.12) and FM (P 0.20) (Table 3) in the presence of positive association results with FFM (Table 6 ).
The CTTT repeat showed evidence of linkage and association with FFM, particularly in heavier males and females, and the K656N polymorphism exhibited associations with FFM and FM, with borderline linkage results. These two polymorphisms are located in exon 14 and in intron 16, respectively, and span the exon 16 encoding in human the amino acid sequence equivalent to the region where is found the rat Lepr fak mutation. The CTTT polymorphism is also not far from the location of the mouse Lepr db mutation (Figure 1) . 17, 30 The mouse Lepr db and Lepr fak mutations both produce a truncated receptor without the cytoplasmic domain. It could be hypothesized that the K656N and CTTT polymorphisms represent alleles that could be related to a change in the cytoplasmic domain properties of human LEPR. In the only other study showing good evidence of a positive result, a nucleotide change ( 7 36AaT), located in the same intron 16 than the CTTT repeat, and two other variants ( 37CaA and 3057GaA), located in the cytoplasmic part of LEPR (Figure 1) , were shown to be positively associated with body fat in Pima Indians. 32 At least one Janus protein-tyrosine kinase (JAK) and one signal transducers and activators of transcription (STAT) consensus-binding sites are found in the cytoplasmic domain of LEPR ( Figure  1 ), and these JAK and STAT sites are the most probable way by which the signal from leptin is potentially relayed to the nucleus for the activation of genes controlling feeding. 18,45 ± 47 In the mouse, two duplicate cytokine domains (C domain) have been reported in LEPR. 22 These domains represent two putative leptin binding regions of the receptor, and are encoded by exons 3 to 6, and exons 8 to 11, respectively. 19 This corresponds in human to exons 5 to 8, and 10 to 13, with the two cytokine motives located in exons 8 and 13, respectively ( Figure 1) . The substitution Q223R, that we studied in QFS, is located in exon 6 within the ®rst C domain. The Zucker rat mutation in the leptin receptor (Lepr fa ) is located in human exon 7, closed to exon 6 and also in the ®rst C domain of LEPR (Figure 1 ). 31 Lepr fa involves the substitution of a Q residue at position 269 (270 in human) for a P residue which affects the functionality of the receptor. 13, 14, 18 The Q223R polymorphism has been shown to be linked to FM and FFM in the QFS, and to be associated with FFM in the QFS or the BMI in a British population. 33 It could be hypothesized that the single amino acid change observed in human exon 6 (Q223R) could eventually change the binding capacity of LEPR to leptin as observed for the Lepr fa mutation in the rat. It is obvious that the amino acid substitution in human LEPR at codon 223 also involves, as in the rat, a glutamine (Q) residue, and that this Q residue, similarly to lysine (K) for the K656N polymorphism, has been reported to be conserved between mouse and human. 22 The weak association between the BMI and Q223R, observed in white British lean subjects, 33 could be similar to the one we observed in QFS, since the largest fraction of body mass in normal weight subjects is FFM. Functional assays using the two types of receptor could help to clarify the putative effect of the Q223R and K656N polymorphisms of LEPR on FFM and FM.
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Conclusion
The results in QFS, support the hypothesis of an effect of LEPR on body composition in humans, with a particular in¯uence to FFM in obese subjects. The possibility of a linkage disequilibrium with other nearby genes cannot be ruled out. However, this is an unlikely scenario, since LEPR is a strong candidate for obesity, based on its direct role in mouse and rat obesity models, and because the stronger results reported here are those obtained with allelic variants located within, or near, regions that are thought to be critical for the function of the leptin receptor. Negative and positive associations for the same allelic variant in subgroups of the same population suggest that variations at other genes are involved in modulating the effect of LEPR on human body composition. This emphasizes the need for more complex analyses, incorporating information on more re®ned obesity phenotypes and multiple genes and mutations, most of which have not yet been identi®ed.
